1-833-ZEPOSIA

ZEPOSIA is a once-daily pill for adults with moderate to severe ulcerative colitis (UC).

Take as directed by your doctor if certain liver problems exist.

MenuClose

ZEPOSIA is a once-daily pill for adults with moderate to severe ulcerative colitis (UC).

Take as directed by your doctor if certain liver problems exist.

ZEPOSIA 360 Support

The ZEPOSIA 360 Support program has materials and resources designed to help you get the support you need, whether you’re considering ZEPOSIA or are already getting started with treatment.

Sign up for 360 Support

Which best describes you?

Let us know where you are in your treatment journey so we can provide support that works for you.

Magnifying glass icon

I’m considering ZEPOSIA

ZEPOSIA 360 Support has information that can help you find out if ZEPOSIA may be right for you.

Message icon

We’ll keep you updated and informed

By signing up for ZEPOSIA 360 Support communications, you'll receive the latest information sent directly to you, including:

  • Information about ZEPOSIA
  • A guide for talking to your UC healthcare team
  • Stories from real people taking ZEPOSIA
  • A brochure with more information mailed directly to you
  • Helpful alerts sent to your phone (optional)
Sign up for 360 Support
ZEPOSIA® pill icon

I’m getting started or currently taking ZEPOSIA

When you begin treatment with ZEPOSIA, you'll have support available to you every step of the way. A dedicated Support Coordinator can help determine your coverage for ZEPOSIA, what your out-of-pocket costs may be, and other financial options.

ZEPOSIA® 360 Support - support coordinator icon

Connecting with a Support Coordinator

Once you’re prescribed ZEPOSIA, a Support Coordinator will contact you to welcome you to the program and guide you through the support offerings. If you haven't heard from a Support Coordinator, reach out to your healthcare team to ensure that your Start Form (your ZEPOSIA prescription) was submitted to ZEPOSIA 360 Support.

Our Support Coordinators can:

  • Help navigate your insurance benefits*
  • Assist you in exploring available support and savings options
  • Arrange for eligible, commercially insured patients to get ZEPOSIA in the event of delays or issues with insurance coverage
  • Assist eligible, commercially insured patients with scheduling the routine tests needed to start ZEPOSIA

Additional support team members are also available to answer questions about ZEPOSIA and provide helpful resources.

1-833-ZEPOSIA (1-833-937-6742), Monday to Friday, 8 AM to 8 PM ET.

  • The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.
Dollar sign icon

Ways to save on treatment costs

There are also many ways to save on treatment costs, including:

  • A co-pay offer that helps those who are eligible and commercially insured pay as little as $0 a month for ZEPOSIA
  • Reimbursement for medical costs associated with appointments or routine tests before starting ZEPOSIA, for eligible, commercially insured patients
  • The ZEPOSIA Bridge Program may provide help for eligible, commercially insured patients who are experiencing a delay in obtaining coverage or have been denied coverage
  • If you have difficulty affording your medication, our Support Coordinators can help you identify options that may be available to you

Additional eligibility requirements and terms & conditions apply. Please see below and click here for more information.

  • The Bridge Program is available at no cost for eligible, commercially insured, on-label diagnosed patients if there is a delay in determining whether commercial prescription coverage is available, and is not contingent on any purchase requirement, for up to 24 months (dispensed in 30-day increments). The Bridge Program is not available to patients who have prescription insurance coverage through a state or federal healthcare program, including but not limited to Medicare, Medicaid, Medigap, CHAMPUS, TRICARE, Veterans Affairs (VA), or Department of Defense (DoD) programs and is available for no more than 12 months to patients in MA, MN, and RI. Appeal of any prior authorization denial must be made within 90 days or as per payer guidelines, to remain in the program. Eligibility will be re-verified in January for patients continuing into the following year, and may be at other times during program participation. Offer is not health insurance. Once coverage is approved by the patient’s commercial insurance plan, the patient will no longer be eligible. Void where prohibited by law, taxed, or restricted. Bristol-Myers Squibb Company reserves the right to rescind, revoke, or amend this program at any time without notice. Other limitations may apply.
Message icon

We’ll keep you updated and informed

As a part of ZEPOSIA 360 Support communications, you’ll receive the latest information sent directly to you, including:

  • Information about ZEPOSIA
  • Tips for starting and staying on treatment
  • Ways to live a healthy lifestyle that can have an impact on UC
  • Links to helpful resources
  • A brochure for starting ZEPOSIA mailed directly to you
  • Helpful alerts sent to your phone (optional)
Sign up for 360 Support
Hand holding mobile phone with apps icon

An app to help you get started and stay on track

The Redi.Health for ZEPOSIA app is a tool that can help support you on your UC journey. It includes medication tracking, UC-friendly recipes, information on ZEPOSIA, and more.

Get started by downloading the Redi.Health app from your mobile device and entering code ZEPOSIA.

Download on Apple Store button Download on Google Play button

Rather use the online version? Click here to sign up and get started.